[Acute hematogenous osteomyelitis and purulent arthritis in childhood. A 10-year study from the county of Copenhagen with a follow-up].
BACKGROUND
The proper treatment of patients with acute haematogenous osteomyelitis and acute suppurative arthritis is still controversial. Based on a previous study, a treatment regimen was recommended. We now report on the clinical, bacteriological, and radiological aspects of the diseases, with special attention to possible changes in the natural history of the diseases and the long-term prognosis.


METHODS
A total of 69 children with acute haematogenous osteomyelitis and 48 with septic arthritis admitted in the period 1977-1987 were entered in a retrospective review. Epidemiological and bacteriological data were analysed and compared to those of an earlier study (1965-1974), confined to the same geographical area. Long-term outcome was assessed by a questionnaire and clinical-radiographic follow-up.


CONCLUSIONS
A significant increase in the admission rate for both disorders was seen. The long-term outcome was favourable, with major sequelae found in only three patients (3%) and minor sequelae in two patients (2%). The benign long-term outcome may well be related to quick admittance to hospitals and long-lasting, appropriate antibiotic treatment.
D000208:Acute Disease; D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D001170:Arthritis, Infectious / Q000150:complications / Q000453:epidemiology / Q000382:microbiology / Q000628:therapy; D002648:Child; D002675:Child, Preschool; D003718:Denmark / Q000453:epidemiology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D008297:Male; D010019:Osteomyelitis / Q000150:complications / Q000453:epidemiology / Q000382:microbiology / Q000628:therapy; D011379:Prognosis; D012189:Retrospective Studies; D011795:Surveys and Questionnaires
D000900:Anti-Bacterial Agents
Akut haematogen osteomyelit og purulent artrit i barnealderen. En 10-års opgørelse fra københavns amt med efterundersøgelse.